Tag Archive

Alzheimer’s Fingerprick Tests: Why Blood-Based Biomarker Trials Matter

Early diagnosis has long been one of the greatest challenges in Alzheimer’s disease. For decades, clinicians have been forced to rely on expensive brain scans, invasive lumbar […]

New Alzheimer’s Disease Prevention Developments

A recent study from R. Scott Turner, PHD, MD–one of our Principal Investigators at Re:Cognition Health USA–shows that both mild cognitive impairment (MCI) and dementia cases are […]

Groundbreaking Early Alzheimer’s Detection Potentially Found

  An early study was done using blood testing to discover Alzheimer’s ahead of time. The tests track certain protein problems and levels in the blood that […]

Leukemia Drug Shown to Lower Risk of Alzheimer’s

The first oral drug shown to combat Alzheimer’s causing proteins in patients A research study on Nilotinib, an FDA-approved drug which is used to treat Leukemia, has […]